ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

BYOT Byotrol Plc

0.15
-0.225 (-60.00%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Byotrol Plc LSE:BYOT London Ordinary Share GB00B0999995 ORDS 0.25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.225 -60.00% 0.15 0.10 0.20 0.275 0.075 0.28 36,795,174 10:34:07
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Chemicals & Chem Preps, Nec 4.59M -1.69M -0.0037 -0.41 680.84k
Byotrol Plc is listed in the Chemicals & Chem Preps sector of the London Stock Exchange with ticker BYOT. The last closing price for Byotrol was 0.38p. Over the last year, Byotrol shares have traded in a share price range of 0.075p to 2.60p.

Byotrol currently has 453,890,405 shares in issue. The market capitalisation of Byotrol is £680,836 . Byotrol has a price to earnings ratio (PE ratio) of -0.41.

Byotrol Share Discussion Threads

Showing 7476 to 7500 of 16100 messages
Chat Pages: Latest  308  307  306  305  304  303  302  301  300  299  298  297  Older
DateSubjectAuthorDiscuss
27/1/2020
10:40
Seems a no brainer to me....
kcowe
27/1/2020
10:29
Whatever the counter arguement,I believe that the Byotrol BoD should use this occasion to at least raise the profile of the product and its claims in the UK, in addition to early issuances in the USA. .

"ATLANTA - January 24, 2020 - (Newswire.com)

"​​The Wuhan coronavirus, a new and potentially fatal infection, has arrived in the U.S. The first confirmed U.S. case of the coronavirus in Washington state has CDC officials and hospitals across the U.S. preparing for the possibility of the virus spreading here. Fortunately, a new EPA-registered multi-surface cleaner not only eradicates coronaviruses and other dangerous viruses but also kills bacteria for 24 hours with a formulation classified as nontoxic by the EPA. The product is called Byotrol24™ (www.Byotrol24.com) and is available at Target.com."

That Newswire story is being picked up in the States and repeated.

mudbath
27/1/2020
10:26
Could the new slogan be "Use Byotrol to help protect your family from the Corona virus"

Looks like Byotrol USA have already beaten me to it!! Well done the team

New Multi-Surface Cleaner Kills Coronavirus & Sanitizes for 24 Hours




Edited - Jst seen Mudbath already beaten me to the post - However needs repeating and repeating -

Maybe all airlines should now use to try and limit cross infection from surfaces?? - New airline slogan needed -

pugugly
26/1/2020
22:49
Several small initiatives to be launched in 'New Year' so around now...

Any of those small initiatives starting would affect the full year results, wouldn't they, 1gw??? So any of these have nothing to do with closing a US Partnership deal....but nice try...


From the interims:


Despite very limited resource investment in non-pet consumer, we are making good progress in household products with some new, initially small, launches expected in the New Year:

-- Following the acquisition of Hero Pet Brands earlier this year, Manna Pro's UK division is launching a Multi-Surface Disinfectant Cleaner, powered by Byotrol, under their market-leading Simple Solution brand into the UK pet market in February 2020

-- Iconic British heritage brand, Swan, has added Byotrol carpet detergents into its new floorcare offering. Marketed under the new Swan Dirtmaster brand, the range launches into retail stores in the UK in March 2020

-- RK Wholesale Ltd have selected Byotrol formulations for their new range of UK floorcare products marketed under their long-standing Tower brand, which has provided consumers with home appliances since 1912, the new range will be launched in March 2020.

sikhthetech
26/1/2020
15:38
1gw,

"that at least 1 of those opportunities should be closed by the end of the financial year - otherwise how would it affect full year results?"

I agree on that point.
BUT
it doesn't mean that they are close to 'closing a US partnership', which is what you were implying in your previous posts and I was disagreeing with.

The US trial at target is due to finish end of March... So they could also mean that they believe the current trial will end and further extension of the trial or a full out to Target is expected...which again is different from closing a alternative partnership, which is what you're saying..

sikhthetech
26/1/2020
15:28
Specifically on the timeline for the US deal, they announced in September that they were seeking a partner (financial or corporate).

In November, at the AGM I was able to talk to them a little about process and I came away with a clear impression that they were hoping to conclude something within a few months. I think I actually volunteered the timescale and they didn't really push back on it - but for a single product deal, how much time do you need? There is limited due diligence a counter-party would need to do so critical path is likely (IMO) to be the bid process (number of rounds and time between rounds perhaps) byotrol and its adviser wanted to put in place to secure maximum value, plus the detail of closing in terms of putting a fully-termed agreement in place once heads of terms were agreed.

In December, the finnCap note stated that they were preparing for the Target trial to finish at the end of March.

Also in December, in the finnCap note there was the statement that "The company confirmed that it is now engaged in a number of early-stage discussions to partner Byotrol 24 in the US" and "Byotrol has indicated that an alternative relationship with a better risk/reward profile can be in place by then." [i.e. in H2].

There are never any guarantees in business development - negotiations can always blow up at the last minute and there are frequently delays which arise unexpectedly.

But in my mind the evidence is fairly clear that the company was hoping to close a US deal by the end of March, and if that one was delayed or fell through there were other deals (possibly out-licensing non-core technology) that might be delivered by then. For that to be the case, in my opinion they would by now be well down the road of trying to get to close on at least one of the deals, to allow for last minute delays and still be able to get to absolute close by the end of March, so that the financial impact would come into FY20 results.

1gw
26/1/2020
15:10
stt - If a company states in December that it is working on a number of business development and monetisation opportunities that should improve results for the full year, there is in my mind a clear implication that at least 1 of those opportunities should be closed by the end of the financial year - otherwise how would it affect full year results?

Given they apparently failed to close a big deal by the end of full-year FY19, despite suggesting in the FY19 interims that they might close one ("Quite how positive the year end will be will depend on which larger deals we close before year end…"), I believe they will have examined this year's (i.e. December 2019) statement very closely before making it and would have wanted to be highly confident that they would close a deal this time.

You're free to interpret the statements differently of course, and I'm not trying to provide any advice - just explaining why I have been buying, why I think there is good "option value" in the shares at this level, and why I believe the priority for the company right now is probably closing one of these deals rather than investing time and resources in UK-targeted publicity linked to coronavirus.

1gw
26/1/2020
14:24
1gw

"finnCap note, 19th December (talking about Byotrol24 and the Target in-store trial expected to lapse in March):
"Byotrol has indicated that an alternative relationship with a better risk/reward profile can be in place by then.""


"INDICATED" "CAN BE IN PLACE" is no different from their interim statement also indicated that they are continuing to SEARCH for a partner via an agency...

Their interims were announced over a month ago and they HOPE to find a partner by end of March... But that's not the same as closing a partnership or completing a deal, which is what you were stating in your previous posts...
There's no indication in the interims or since that they are talking to prospective partners, is there?

sikhthetech
25/1/2020
17:32
Interim statement, 19th December:
"The team is also working on a number of business development and monetisation opportunities that should improve results for the full year"

finnCap note, 19th December (talking about Byotrol24 and the Target in-store trial expected to lapse in March):
"Byotrol has indicated that an alternative relationship with a better risk/reward profile can be in place by then."

Given the statement made in the FY19 interims (December 2018) about closing deals by that year-end, I think it would be rash to offer such sentiments again this year without being very confident that they could be delivered this time.

1gw
25/1/2020
17:29
1gw
"And byotrol in the uk may well stand to benefit in particular through increased sales into the nhs under the sc johnson deal."


Glad you agree that Byot might benefit if they also focus on NHS rather than just US, as I stated in my post 3951 yesterday..

;-)



sikhthetech24 Jan '20 - 16:07 - 3951 of 3959 Edit
0 2 2

<...>
"However, 24hr protection is useful in hospitals and care homes etc, where there is cleaning once a day..."

sikhthetech
25/1/2020
17:21
1gw

"In the US they are still trying (presumably) to close a major partnership deal"
"deal completion should be near the top of the list"

Where have you read that they are CLOSE to a partnership or a deal completion???

According to their interims they are still SEARCHING for a partner...
and the trial at Target is due to finish at end of March, so at company year end...
How has that trial gone?

They said in May last year that they were CLOSE to securing a 2nd retailer but haven't heard any more so seems like that retailer pulled out, doesn't it?



"We continue our search for a partner for Byotrol24 in the US and have engaged professional advice to assist. Sales at Target continue to increase year on year and month on month, but are not large enough to justify continued, national marketing spend by us even at very small levels. We are now preparing for the trial at Target to finish at the end of March 2020."




"We are also now close to securing an additional new national retailer trial in the US."

sikhthetech
25/1/2020
16:17
Indeed it might, not least in the US. But the company has to prioritize given its very limited human resources. Right now I would have thought deal completion should be near the top of the list and then once we get into April execution on synergy delivery will be important.

But in general an extended coronavirus scare should be a positive for the whole sector, I would have thought. And byotrol in the uk may well stand to benefit in particular through increased sales into the nhs under the sc johnson deal.

1gw
25/1/2020
16:11
True 1gw.
YET,
In 2009,at the time of the last serious scare,Byotrol sales rocketed,enabling the Company to post a profit.
The coronavirus might just prove to be the catalyst for a deal or two being secured.

mudbath
25/1/2020
13:54
mudbath - the context is very different for UK and US surely?

In the US they are still trying (presumably) to close a major partnership deal for consumer which would lead to $5m or so of marketing spend aimed at getting to $20m in sales. So in that context, it is worth putting out some publicity around the product - primarily to reinforce the selling points to potential investing partners but perhaps also as very low-level ongoing consumer marketing ahead of the hoped for major spend.

In the UK, total consumer segment sales in FY19 were only £164k, and I think most of that would have been in products with principal branding belonging to someone else (e.g. Tesco). In this year's interims they comment "Headline H1 revenues in this [consumer] segment were £0.41m...Petcare remains the largest element of day-to-day sales in consumer, accounting for 92% of consumer sales in the period."

So there's just not much to leverage in the UK (consumer non-pet, byotrol-branded) at the moment, is there? Would it really be worth spending time and resources putting out UK-focused publicity on byotrol/Invirtu's potential when the company is trying to close a number of business development/monetisation opportunities by financial year-end? Remember Medimark is apparently still silo'd while the earn-out completes, so where should Byotrol take resources from to manage UK consumer publicity at this very early stage of the coronavirus scare?

1gw
25/1/2020
10:06
Where is a similar UK news release Mr Traynor ?
mudbath
25/1/2020
10:03
Although BYOT saw a 3million share sale a couple of days ago,the MMs surprisingly remain keen to buy in size(1million).

There looks to be significant potential at these levels(circa 1.6 pence) for investors to benefit from a rising share price.

Over the pond Alex Espalin is on the case !

ATLANTA - January 24, 2020 - (Newswire.com)

"​​The Wuhan coronavirus, a new and potentially fatal infection, has arrived in the U.S. The first confirmed U.S. case of the coronavirus in Washington state has CDC officials and hospitals across the U.S. preparing for the possibility of the virus spreading here. Fortunately, a new EPA-registered multi-surface cleaner not only eradicates coronaviruses and other dangerous viruses but also kills bacteria for 24 hours with a formulation classified as nontoxic by the EPA. The product is called Byotrol24™ (www.Byotrol24.com) and is available at Target.com. Byotrol24 sells for $3.99 in a liquid spray bottle and is available in two long-lasting scents: Lavender Morning™ and Hawaiian Sunrise Citrus™.

Byotrol24 is scientifically proven to eliminate coronaviruses, noroviruses, flu and cold viruses, E. coli, salmonella, staph, strep, listeria, Pseudomonas aeruginosa and other germs. Of particular note, not all surface cleaners sold in stores today are capable of eliminating the hard-to-kill norovirus, sometimes referred to as the winter vomiting bug. Spreading person to person easily, norovirus is reported by the CDC to result in up to 71,000 hospitalizations each year.

Although not much is known about the novel Wuhan coronavirus, it appears capable of spreading human to human and is in the same family as the virus that causes SARS, which killed more than 700 people in 2002-03. With no vaccine available, effective hygiene and cleaning practices are a front line of defense.

Byotrol24 is specially formulated as a non-harsh disinfectant and long-lasting sanitizer that emits no chemical fumes and requires no gloves for use....

Byotrol24 is a scientific breakthrough in germ control. It has been thoroughly tested and proven to kill a wide range of germs, including coronaviruses, and to control germs for a long period of time,” said Dr. Trevor Francis, chief technology officer for Byotrol. “This EPA-registered, nontoxic disinfecting formula with 24-hour sanitizing power can help stop the spread of germs and potentially save lives.”

Read more: hxxp://www.digitaljournal.com/pr/4567608#ixzz6C2EeMpgQ

mudbath
24/1/2020
16:36
Sikh=try and get a life.
cumnor
24/1/2020
16:12
Brownson,

"You would expect Byotrol to be shouting from the rooftops that their product just might be relevant in the current situation."


absolutely, they would be trying to attract attention of NHS bosses etc. Not just in UK but also health bosses around the world...
It would also attract attention of potential IIs...
However any disinfectant would kill conovarious...

But nothing so far!!

sikhthetech
24/1/2020
16:07
The point is Coronavirus' have initially discovered in the 1960s, new strains appear but disinfectants kill them...
A lot of hospitals, working environments, food outlets are already aware due to MRSA, Swine flu etc that they must disinfect and clean regularly...

Using disinfectants is nothing new and Byotrol is no more effective than other disinfectants.... As to duration, consumers who are concerned about virus/bacteria etc would clean their kitchen after each use, so whether the disinfectant is effective for 2hrs or 24hrs makes no difference...
However, 24hr protection is useful in hospitals and care homes etc, where there is cleaning once a day...

sikhthetech
24/1/2020
15:41
Why would they be doing that Brownson? They're not geared up for big (human) consumer marketing campaigns. They are effectively trying to outsource major consumer through Solvay for Actizone and the US partner that they're currently seeking for byotrol24 aren't they? I think we can be sure that on professional sales (Medimark and eg. the SC Johnson deal into the NHS) the buyer is aware of the product abilities and how it is differentiated. But that doesn't need big consumer campaigns.

The reason I mentioned the coronavirus thing on byotrol24 was (1) I noticed it was there on the website and (2) I interpreted that as meaning they would be flagging it up to potential trade/investor partners in the US process.

I don't think it is a biggie, which is why I used the phrase "can't do any harm", but you never know what might get someone's attention so I think it is worthwhile byotrol making the point (to potential trade/investor partners). byotrol24's usp is (I think) its 24-hour duration and that combined with its effectiveness against coronavirus, should coronavirus become a more serious factor in the US in the coming months, might just be an attractive combination for some potential partners.

1gw
24/1/2020
15:15
You would expect Byotrol to be shouting from the rooftops that their product just might be relevant in the current situation. They should be on every news programme , "good morning" , breakfast TV etc but they are actually pretty clueless.
brownson
24/1/2020
09:54
1gw,
Glad you agree that other disinfectants kill coronavirus as well..it's not unique to byotrol as you were implying...

I wonder who sold 3m???

sikhthetech
24/1/2020
08:02
How many of the other disinfectants have a 24 hour claim as well?

"eliminate OVER 99.9% of germs and keep surfaces sanitized for 24 HOURS"

The whole point of the current exercise is to try to secure a partner to fund (at least most of) the $5m or so of marketing spend that they think is necessary to get byotrol24 sales up to a meaningful level, isn't it? How they market it will be up to the partner and byotrol to determine, but I think if the coronavirus scare lasts then having a coronavirus angle won't do any harm.

1gw
23/1/2020
22:19
1gw/Mudbath,
""Kills coronavirus" addition to the byotrol24 landing page"
"Will we get the message out in the UK that Byotrol24 kills coronavirus ?"


So do other disinfectants!!!!


Have a search on Target for 'Coronavirus' and you get some disinfecting wipes listed... even if you drill down, you'll get some disinfectants..
Where's Byotrol24???

sikhthetech
23/1/2020
21:23
Hmmm. That's a relatively big trade for recent weeks, so is it possible that's the latest seller finished?

The problem is though that selling can lead to selling if the company can't provide a convincing counter-narrative. Remaining holders look around and wonder if they're wrong - and any remaining institutional holders presumably have a harder time defending their positions in portfolio review/risk management meetings: "If institutions X and Y have sold out, how come we haven't trimmed our position?"

Come on byotrol. Let's get one of those deals concluded and announced!

1gw
Chat Pages: Latest  308  307  306  305  304  303  302  301  300  299  298  297  Older

Your Recent History

Delayed Upgrade Clock